Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > MIT Enterprise Forum of Cambridge Presents Session on Life Sciences Marketplace Featuring Keynote With Dr. George Whitesides, Co-Founder of Genzyme

Abstract:
What: On March 12, the MIT Enterprise Forum of Cambridge will feature a keynote address by Dr. George Whitesides, life sciences pioneer, successful entrepreneur and currently the Woodford L. and Ann A. Flowers University Professor at Harvard University. Dr. Whitesides' presentation will be followed by a panel discussion with experts in life sciences, focusing on the challenges of collaborating on product development and commercializing technology.

MIT Enterprise Forum of Cambridge Presents Session on Life Sciences Marketplace Featuring Keynote With Dr. George Whitesides, Co-Founder of Genzyme

Cambridge, MA | Posted on March 6th, 2008

Dr. Whitesides is a co-founder of Genzyme and other companies whose combined market capitalization exceeds $20 billion. He has held advisory positions on the National Research Council, National Science Foundation and the Department of Defense's Defense Advanced Research Projects Agency (DARPA).

Following Dr. Whitesides' presentation, Stephen A. Bollinger, president and COO of Pervasis Therapeutics, will present a case study on his company, whose flagship product, Vascugel®, is an allogeneic cell therapy product that restores natural repair and regeneration pathways in the vasculature.

A panel made up of Dr. Ajan Reginald of F. Hoffmann-La Roche and Dr. Harlan Weisman of Johnson & Johnson will discuss the challenges of bringing the cultures and knowledge bases of the pharma, biologics, medical devices and cell therapy markets together to more effectively develop products and establish partnerships. Dr. Doug Levinson, a partner at Flagship Ventures, will serve as moderator.

Keynote Speaker:

Dr. Whitesides joined Harvard's department of chemistry in 1982 and served as department chairman from 1986 to 1989. Prior to joining Harvard, he was a member of the faculty of the Massachusetts Institute of Technology from 1963 to 1982. His present research interests include materials science, biophysics, surface science, polyvalency, microfluidics, optics, self-assembly, microfabrication, nanotechnology and cell surface biochemistry.

Other Speakers:

Dr. Ajan Reginald is global head of emerging technologies in the Roche Research Group of F. Hoffmann-La Roche. Dr. Reginald's group looks to identify the next generation of key biopharma and diagnostics technologies. Dr. Reginald joined Roche in 2005 as the business development director of mergers and acquisitions for Roche Pharma. Previously, Dr. Reginald founded Cosmetic Healthcare Group (CHG), which he later sold. He was awarded a Fulbright Scholarship for the MBA at Kellogg, Northwestern University, where he completed his Ph.D. in 2006.

Dr. Harlan Weisman is chief science and technology officer in the device and diagnostic unit of Johnson & Johnson. Dr. Weisman is a member of the Johnson & Johnson Medical Devices & Diagnostics Group Operating Committee (GOC) and supports the GOC in steering its scientific and technical agenda, leading its investments and sponsoring its research and development agenda. Previously, Dr. Weisman was assistant professor of medicine at Johns Hopkins University School of Medicine.

Dr. Doug Levinson is a partner at Flagship Ventures and focuses on investments in early-stage companies in the biotech industry. He is currently a director of T2 Biosystems after serving as founding CEO, and is on the Board of Resolvyx.

When: Wednesday, March 12, 2008

Networking: 5:30 p.m.

Program: 6:15-8:00 p.m.

Reception: 8:00-9:00 p.m.

Where: Stata Center (Bldg. 32), Kirsch Auditorium, 32 Vassar St., Cambridge

Sponsor: Foley Hoag LLP

Registration and information: www.mitforumcambridge.org/mar08.html

Forum members: $20; Non-members: $30; Students from all universities, free with college ID.

####

For more information, please click here

Contacts:
MIT ENTERPRISE FORUM OF CAMBRIDGE CONTACT:
Regina Smith
MIT Enterprise Forum of Cambridge
617-253-3937

PRESS CONTACT:
Brad Baker (for MIT Enterprise Forum)
CHEN PR, Inc.
781-672-3118

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

New tool allows scientists to visualize 'nanoscale' processes May 4th, 2016

FEI Launches Apreo – Industry-Leading Versatile, High-Performance SEM: The Apreo SEM provides high-resolution surface information with excellent contrast, and the flexibility to accommodate a large range of samples, applications and conditions May 4th, 2016

Little ANTs: Researchers build the world's tiniest engine May 3rd, 2016

An Experiment Seeks to Make Quantum Physics Visible to the Naked Eye May 3rd, 2016

Announcements

New tool allows scientists to visualize 'nanoscale' processes May 4th, 2016

FEI Launches Apreo – Industry-Leading Versatile, High-Performance SEM: The Apreo SEM provides high-resolution surface information with excellent contrast, and the flexibility to accommodate a large range of samples, applications and conditions May 4th, 2016

Nuclear pores captured on film: Using an ultra fast-scanning atomic force microscope, researchers from the University of Basel have filmed 'living' nuclear pore complexes at work for the first time May 3rd, 2016

Little ANTs: Researchers build the world's tiniest engine May 3rd, 2016

Events/Classes

Non-animal approach to predict impact of nanomaterials on human lung published Archives of Toxicology publishes workshop recommendations May 2nd, 2016

Researchers create a first frequency comb of time-bin entangled qubits: Discovery is a significant step toward multi-channel quantum communication and higher capacity quantum computers April 28th, 2016

Introducing the RE標ORK Bio-inspired Robotics Summit in Berlin April 27th, 2016

ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic